Senology.org Newsletter - December 6, 2011

  • 198 views
Uploaded on

Latest Advances in Clinical Senology and Oncology

Latest Advances in Clinical Senology and Oncology

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
198
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Senology Newsletter http://www.senology.org/newsletter/Newsl_Dec2011.htm Senology.org - Newsletter International Senologic and Oncologic Scientific Community "Connecting specialists worldwide" Editor-in-Chief: Gian Paolo Andreoletti, MD Subscribe Unsubscribe Contact Back Issues Connecting Specialists Worldwide Join us on LinkedIn, ResearchGate, Doctorsbook, Twitter, Facebook, Google Groups, YouTube, SlideShare, Flickr, and share informations and opinions. Check out Senology.org Newspaper and follow our RSS feeds for real-time updates Literature Selection Romero C et al.: "Impact on breast cancer diagnosis in a multidisciplinary unit after the incorporation of mammography digitalization and computer-aided detection systems", AJR Am J Roentgenol. 2011 Dec;197(6):1492-7 Cho N et al.: "Distinguishing Benign from Malignant Masses at Breast US: Combined US Elastography and Color Doppler US--Influence on Radiologist Accuracy", Radiology. 2011 Nov 14. [Epub ahead of print] Sandri MT et al.: "Prognostic role of CA15.3 in 7942 patients with operable breast cancer", Breast Cancer Res Treat. 2011 Nov 9. [Epub ahead of print] Amir E et al.: "Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer", J Clin Oncol. 2011 Nov 28. [Epub ahead of print] Fasching PA et al.: "Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment", BMC Cancer. 2011 Nov 14;11(1):486. [Epub ahead of print] He X et al.: "Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer", Ann Oncol. 2011 Nov 22. [Epub ahead of print] Pellegrini I et al.: "Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients misinterpretations and positive attitudes", Eur J Cancer Care 2011 Nov 9 [Epub ahead of print] Romano S et al.: "Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients", Br J Cancer. 2011 Nov 8. doi: 10.1038/bjc.2011.439. [Epub ahead of print]1 di 3 06/12/2011 15:51
  • 2. Senology Newsletter http://www.senology.org/newsletter/Newsl_Dec2011.htm Wang J et al.: "Predictors of Nipple-Areolar Complex Involvement by Breast Carcinoma: Histopathologic Analysis of 787 Consecutive Therapeutic Mastectomy Specimens", Ann Surg Oncol. 2011 Nov. [Epub ahead of print Kesler SR et al.: "Prefrontal cortex and executive function impairments in primary breast cancer", Arch Neurol. 2011 Nov;68(11):1447-53 Pemmaraju N et al.: "Retrospective review of male breast cancer patients: analysis of tamoxifen- related side-effects", Ann Oncol. 2011 Nov 15. [Epub ahead of print] Comment "Intermediate mammograms increase the false-positive rate except in specific groups" - Nieves Ascunce Elizaga, Navarra Breast Cancer Screening Programme, Public Health Institute, Pamplona, Spain ""Intermediate mammograms (IM) in breast screening offer potential benefits but also disadvantages, like false positives (FP) results. Although annual screening has not been shown to reduce more the mortality than biennial screening, some studies have reported an increased detection rate, detection of smaller tumours and a reduction in interval cancers. On the other hand, in the whole IMs increase the rate of FP. However in the case of younger women undergoing their initial screen and those with risk factors (previous invasive procedures, a family history of breast cancer or hormone replacement therapy use) the risk of a FP result is significantly lower. In order to guarantee the quality of screening programmes, a better characterization of the IM indications should be done, according to the presence of those maximising benefits and minimising adverse effects" (Comment on: Ascunce N et al.: "Impact of intermediate mammography assessment on the likelihood of false-positive results in breast cancer screening programmes", Eur Radiol. 2011. [Epub ahead of print]) Discussion - Article in The Lancet: MRI of little benefit to women with breast cancer despite its increasing use. What do you think? Share your opinion on LinkedIn® Calendar of Events The 2011 CTRC-AACR San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX The World Cancer Immunotherapy Conference, January 25-26, 2012, San Diego, CA Fragments of History William S Halsted (New York, 1852-1922), "The results of radical operations for the cure of carcinoma of the breast", Ann Surg. July 1907:46(1):1-19: “Fortunately we no longer need the proof which our figures so unmistakably give that the slightest delay is dangerous and that, other things being equal, the prognosis is quite good in the early stage of breast cancer, two in three being cured, and bad, three in four succumbing, when the axillary glands are demonstrably involved" Literature Selection Engels EA et al.: "Spectrum of cancer risk among US solid organ transplant recipients", JAMA. 2011 Nov 2;306(17):1891-901 Aune D et al.: "Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies", BMJ. 2011 Nov 10;343:d6617. doi: 10.1136/bmj.d6617 Meng Z et al.: "Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma", Cancer. 2011 Nov 9. doi: 10.1002/cncr.26550. [Epub ahead of print] Chen QY et al.: "Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial", J Natl Cancer Inst. 2011 Nov 4. [Epub ahead of print] Castro MR et al.: "Predictors of malignancy in patients with cytologically suspicious thyroid nodules", Thyroid. 2011 Nov;21(11):1191-8 Warde P et al.: "Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial", Lancet. 2011 Nov 2. [Epub ahead of print]2 di 3 06/12/2011 15:51
  • 3. Senology Newsletter http://www.senology.org/newsletter/Newsl_Dec2011.htm Azoulay L et al.: "Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer", Eur Urol. 2011 Dec;60(6):1244-50 Kim DY et al.: "Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma", Oncology. 2011 Nov 8;81(3-4):184-191. [Epub ahead of print] Aftab BT et al.: "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer", Cancer Res. 2011 Nov 1;71(21):6764-72 Dhar SU et al.: "Outcomes of integrating genetics in management of patients with retinoblastoma", Arch Ophthalmol. 2011 Nov;129(11):1428-34 Literature Selection Moorman PG et al.: "Effect of Hysterectomy With Ovarian Preservation on Ovarian Function", Obstet Gynecol. 2011 Nov 7. [Epub ahead of print] Imkampe AK et al.: "Correlation of Age at Oral Contraceptive Pill Start with Age at Breast Cancer Diagnosis", Breast J. 2011 Nov 8. doi: 10.1111/j.1524-4741.2011.01181.x. [Epub ahead of print] Crandall CJ et al.: "Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone womens health initiative clinical trials", Breast Cancer Res Treat. 2011 Nov 1. [Epub ahead of print] Senology.org collaborates with TalkAboutHealth.com - "Breast cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation Stay informed.... Recent Advances in Clinical Medicine Dooley MA et al.: "Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis", N Engl J Med. 2011 Nov 17;365(20):1886-95 Unsubscribe www.senology.org3 di 3 06/12/2011 15:51